Search

everythinglearnresearchcommunity

for

Search:↓

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Post-COVID-19 patients are at risk for hair loss.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Essential oils may improve dogs' health and melatonin can help with their sleep and anxiety, but both should be used carefully.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

The machine learning model accurately detected hair loss and scalp diseases using processed images.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Plant bioactive compounds are important for health and can help prevent various diseases.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Thyroid function may influence hair loss after COVID-19.

The pandemic stress may have increased alopecia cases in Bangladesh.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.